30 Mar
The FDA’s First Moves
INTRODUCTION The touchstone of clinical research is the randomized controlled trial (RCT). This is the design preferred for studies that face academic scrutiny through peer review, and it is the required research paradigm for findings that are submitted to the Food and Drug Administration (FDA) to support New Drug Applications (NDAs). The probative value as [...]